Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G26414-10 | 10 µg | $265 |
| LS-G26414-50 | 50 µg (0.22 mg/ml) | $315 |
| LS-G26414-100 | 100 µg | $365 |
Human CD44 Protein (Recombinant 6His, N-terminus) (Gln21-Pro220) - LS-G26414
Human CD44 Protein (Recombinant 6His, N-terminus) (Gln21-Pro220) - LS-G26414
Description:
CD44 Protein LS-G26414 is a Recombinant Human CD44 produced in E. coli Gln21-Pro220 with 6His, N-terminus tag(s). For Research Use Only
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
CD44 Protein LS-G26414 is a Recombinant Human CD44 produced in E. coli Gln21-Pro220 with 6His, N-terminus tag(s). For Research Use Only
Specifications
Type
Recombinant Protein
Target
CD44
Synonyms
CD44 | CDW44 | CD44 antigen | Cell surface glycoprotein CD44 | CSPG8 | ECMR-III | Epican | HUTCH-I | LHR | MDU2 | MC56 | MIC4 | Hermes antigen | Hyaluronate receptor | Phagocytic glycoprotein 1 | PGP-1 | PGP-I | Pgp1 | Phagocytic glycoprotein I | MDU3 | CD44R | HCELL | Heparan sulfate proteoglycan
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Tag
6His, N-terminus
Region
Gln21-Pro220
Predicted Molecular Weight
24 kDa
Expression System
E. coli
Source Species
E. coli
Purification
Greater than 95% by SDS-PAGE
Usage Summary
Recommended applications: ELISA, Western blotting, Dot Blotting, Immunogen, Protein Array
Bio-Activity
Not Tested
Endotoxin
Not Tested
Presentation
Sterile solution in 40 mM Tris-HCl, pH 8.5, 50 mM NaCl.
Storage
Short term: Store at 4 °C for up to 2 weeks. Long term: Store lyophilized at -20 °C in a dessicator or aliquot and store at -80 °C. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About CD44
LSBio Ratings
Human CD44 Protein (Recombinant 6His, N-terminus) (Gln21-Pro220) - LS-G26414 has an LSBio Rating of
Publications (4)
Learn more about The LSBio Ratings Algorithm
Publications (1)
New monoclonal antibodies that recognize an unglycosylated, conserved, extracellular region of CD44 in vitro and in vivo, and can block tumorigenesis. Daniel F Lusche, Deborah J Wessels, Ryan J Reis, Cristopher C Forrest, Alexis R Thumann, David R Soll. PloS one. 2021 Apr;16:e0250175.
Customer Reviews (0)
Popular CD44 Proteins
Source:
E. coli
Tag:
6His-SUMO, N-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/23/2024
Date Requested: 11/23/2024
